Clinical Trial ECOGTHNR1016


Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Principal Investigator(s)

Kenneth Niermann


  • Protocol No. ECOGTHNR1016
  • Open Date: 09/25/2012
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective: To determine whether substitution of cisplatin with cetuximab will result in comparable 5-year overall survival
  • Disease Sites: Head/Neck
  • Therapies: Chemotherapy - cytotoxic; Molecular Targeted Agents / Immunotherapy / Biologics; Radiotherapy
  • Drugs: Cetuximab; Cetuximab (Erbitux); Cisplatin
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: 01302834
  • Secondary Protocol No: RTOG 1016